Zeiss organized the specialized workshop series, "The Future of Myopia Progression Management in Vietnam," in Hanoi (7/6), Da Nang (12/6), and Ho Chi Minh City (19/6), bringing together ophthalmologists, vision experts, and specialized units nationwide. The workshop will continue in Can Tho (26/6) and include a webinar (3/7).

According to the organizing committee, the event series aims to update the latest advancements in ophthalmology, given the rapidly increasing rate of school myopia in Vietnam and many countries globally. The search for effective solutions to control myopia progression has become a top priority for the industry.

Doctor Tran Dinh Minh Huy presents 10 steps for successful myopia control with Zeiss MyoCare lenses. Photo: Carl Zeiss

International studies indicate that myopia is becoming a significant public health concern. In Asian countries, childhood myopia is rising rapidly due to modern lifestyles, extended study hours, and widespread use of electronic devices. Experts note that myopia is not merely a refractive error corrected with eyeglasses. Its continuous progression during a child's development can increase the risk of serious eye conditions: retinal degeneration, retinal detachment, glaucoma, or early cataracts.

The workshop series highlighted key topics, including the latest solutions for managing and controlling myopia progression. Speakers shared scientific evidence on comprehensive myopia management strategies: early detection, risk assessment, selecting appropriate interventions for each child, and regular monitoring. Modern myopia management requires coordinating multiple factors: daily habits, outdoor activity time, study regimens, and advanced optical technology.

Guests learn about Zeiss MyoEase lenses. Photo: Carl Zeiss

In addition to scientific discussions, the event introduced Zeiss's myopia progression management ecosystem. This solution supports doctors in monitoring and controlling myopia in children. The ecosystem's most notable feature is its combination of modern measurement devices, clinical data storage software, and advanced optical solutions.

Specifically, the Myo200 vision care solution offers comprehensive refractive examination and in-depth screening. It helps specialists accurately collect biometric parameters of the eyeball, especially axial length – a key indicator for predicting myopia progression.

MyoConsult software is a digital tool that applies modern scientific prediction algorithms, assisting doctors in visualizing a child's myopia progression trajectory.

Zeiss MyoEase myopia progression management lenses combine a C.A.R.E concentric ring micro-structure design and peripheral vision management technology. This reduces retinal myopic defocus and eliminates signals that rapidly lengthen the axial length. The product is expected to meet the diverse needs of patients and ophthalmology professionals.

Furthermore, experts presented the latest clinical data on the effectiveness of Zeiss MyoCare and Zeiss MyoCare S lenses in controlling myopia progression. Research indicates this solution effectively controls myopia while providing daily comfort.

Experts answer questions about clinical cases effectively applying technology from Carl Zeiss. Photo: Carl Zeiss

Zeiss aims to collaborate with the ophthalmology community to raise awareness about myopia management through the workshop series. The event promises to create a forum for professional networking among doctors, experts, and eye care units nationwide.

Zeiss, founded in 1846 in Germany, is a world-renowned technology group specializing in optics and optoelectronics. Wholly owned by the Carl Zeiss Foundation, the company operates in four main areas: semiconductor manufacturing technology (lens optics for chips), medical technology (ophthalmic and microsurgery devices), industrial metrology, and consumer markets (eyeglass lenses, camera lenses, binoculars). Carl Zeiss products are known for high precision and significant continuous investment in scientific research and developing new ophthalmic technologies.

Yen Chi